nodes	percent_of_prediction	percent_of_DWPC	metapath
Buprenorphine—CYP2A6—Methoxsalen—vitiligo	0.618	0.632	CbGbCtD
Buprenorphine—CYP1A2—Methoxsalen—vitiligo	0.236	0.241	CbGbCtD
Buprenorphine—CYP3A4—Methoxsalen—vitiligo	0.124	0.126	CbGbCtD
Buprenorphine—OPRL1—Peptide GPCRs—MC1R—vitiligo	0.00132	0.0603	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide GPCRs—CCR6—vitiligo	0.000989	0.0451	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—MC1R—vitiligo	0.000623	0.0284	CbGpPWpGaD
Buprenorphine—UGT1A9—Estrogen metabolism—GSTM1—vitiligo	0.000584	0.0266	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide GPCRs—MC1R—vitiligo	0.000565	0.0258	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide GPCRs—MC1R—vitiligo	0.000496	0.0226	CbGpPWpGaD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000488	0.0222	CbGpPWpGaD
Buprenorphine—OPRL1—Peptide ligand-binding receptors—CCR6—vitiligo	0.000465	0.0212	CbGpPWpGaD
Buprenorphine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000456	0.0208	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide GPCRs—CCR6—vitiligo	0.000422	0.0192	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide GPCRs—MC1R—vitiligo	0.000419	0.0191	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000418	0.019	CbGpPWpGaD
Buprenorphine—OPRL1—G alpha (i) signalling events—CCR6—vitiligo	0.000392	0.0179	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide GPCRs—CCR6—vitiligo	0.00037	0.0169	CbGpPWpGaD
Buprenorphine—CYP2C18—Tryptophan metabolism—CAT—vitiligo	0.00037	0.0168	CbGpPWpGaD
Buprenorphine—OPRL1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000364	0.0166	CbGpPWpGaD
Buprenorphine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—vitiligo	0.000352	0.016	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—MC1R—vitiligo	0.000318	0.0145	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide GPCRs—CCR6—vitiligo	0.000313	0.0143	CbGpPWpGaD
Buprenorphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.000312	0.0142	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—MC1R—vitiligo	0.000266	0.0121	CbGpPWpGaD
Buprenorphine—UGT1A9—Phase II conjugation—GSTT1—vitiligo	0.000258	0.0117	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—SH2B3—vitiligo	0.000254	0.0116	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR ligand binding—CCR6—vitiligo	0.000238	0.0108	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—MC1R—vitiligo	0.000233	0.0106	CbGpPWpGaD
Buprenorphine—CYP1A2—Estrogen metabolism—GSTM1—vitiligo	0.000214	0.00975	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000208	0.00948	CbGpPWpGaD
Buprenorphine—OPRD1—Peptide ligand-binding receptors—CCR6—vitiligo	0.000199	0.00905	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—MC1R—vitiligo	0.000197	0.00898	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—GSTT1—vitiligo	0.000191	0.00869	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000183	0.00831	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—MC1R—vitiligo	0.00018	0.00819	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000178	0.00812	CbGpPWpGaD
Buprenorphine—OPRK1—Peptide ligand-binding receptors—CCR6—vitiligo	0.000174	0.00793	CbGpPWpGaD
Buprenorphine—OPRD1—G alpha (i) signalling events—CCR6—vitiligo	0.000168	0.00763	CbGpPWpGaD
Buprenorphine—CYP3A4—Estrogen metabolism—GSTM1—vitiligo	0.000165	0.00752	CbGpPWpGaD
Buprenorphine—UGT1A9—Phase II conjugation—GSTM1—vitiligo	0.000164	0.00748	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—MC1R—vitiligo	0.000163	0.00744	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000156	0.00712	CbGpPWpGaD
Buprenorphine—OPRM1—TCR Signaling Pathway—CD8A—vitiligo	0.000156	0.0071	CbGpPWpGaD
Buprenorphine—OPRD1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000155	0.00708	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—MC1R—vitiligo	0.000154	0.00703	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—GSTT1—vitiligo	0.000151	0.00687	CbGpPWpGaD
Buprenorphine—OPRM1—Peptide ligand-binding receptors—CCR6—vitiligo	0.000147	0.0067	CbGpPWpGaD
Buprenorphine—OPRK1—G alpha (i) signalling events—CCR6—vitiligo	0.000147	0.00669	CbGpPWpGaD
Buprenorphine—OPRK1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000136	0.00621	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—MC1R—vitiligo	0.000136	0.00619	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—CCR6—vitiligo	0.000134	0.00612	CbGpPWpGaD
Buprenorphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.000133	0.00607	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—MC1R—vitiligo	0.000132	0.00602	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—GZMB—vitiligo	0.000131	0.00598	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—GSTT1—vitiligo	0.000127	0.00578	CbGpPWpGaD
Buprenorphine—OPRM1—G alpha (i) signalling events—CCR6—vitiligo	0.000124	0.00566	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—CCR6—vitiligo	0.000122	0.00556	CbGpPWpGaD
Buprenorphine—CYP2C18—Biological oxidations—GSTM1—vitiligo	0.000121	0.00554	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CASP7—vitiligo	0.00012	0.00548	CbGpPWpGaD
Buprenorphine—CYP2C18—Metapathway biotransformation—GSTM1—vitiligo	0.00012	0.00546	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—MC1R—vitiligo	0.000119	0.00542	CbGpPWpGaD
Buprenorphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	0.000117	0.00532	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—GSTT1—vitiligo	0.000116	0.0053	CbGpPWpGaD
Buprenorphine—OPRM1—GPCRs, Class A Rhodopsin-like—CCR6—vitiligo	0.000115	0.00525	CbGpPWpGaD
Buprenorphine—UGT1A9—NRF2 pathway—GSTM1—vitiligo	0.000109	0.00499	CbGpPWpGaD
Buprenorphine—CYP1A2—Tryptophan metabolism—CAT—vitiligo	0.000107	0.00487	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CTLA4—vitiligo	0.000106	0.00481	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR ligand binding—CCR6—vitiligo	0.000101	0.00462	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—MC1R—vitiligo	0.000101	0.00458	CbGpPWpGaD
Buprenorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR6—vitiligo	9.87e-05	0.0045	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—MC1R—vitiligo	9.64e-05	0.00439	CbGpPWpGaD
Buprenorphine—UGT1A9—Biological oxidations—GSTM1—vitiligo	9.6e-05	0.00438	CbGpPWpGaD
Buprenorphine—UGT1A9—Metapathway biotransformation—GSTM1—vitiligo	9.47e-05	0.00432	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase II conjugation—GSTT1—vitiligo	9.44e-05	0.0043	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—GSTT1—vitiligo	9.17e-05	0.00418	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR ligand binding—CCR6—vitiligo	8.89e-05	0.00405	CbGpPWpGaD
Buprenorphine—CYP2A6—NRF2 pathway—GSTM1—vitiligo	8.44e-05	0.00385	CbGpPWpGaD
Buprenorphine—CYP3A4—Tryptophan metabolism—CAT—vitiligo	8.26e-05	0.00376	CbGpPWpGaD
Buprenorphine—CYP3A7—Biological oxidations—GSTM1—vitiligo	8.08e-05	0.00368	CbGpPWpGaD
Buprenorphine—CYP3A7—Metapathway biotransformation—GSTM1—vitiligo	7.97e-05	0.00363	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—GSTT1—vitiligo	7.94e-05	0.00362	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—MC1R—vitiligo	7.67e-05	0.0035	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR ligand binding—CCR6—vitiligo	7.52e-05	0.00342	CbGpPWpGaD
Buprenorphine—CYP2A6—Biological oxidations—GSTM1—vitiligo	7.4e-05	0.00337	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—IL2RA—vitiligo	7.32e-05	0.00333	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CCR6—vitiligo	7.2e-05	0.00328	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—GSTT1—vitiligo	7.09e-05	0.00323	CbGpPWpGaD
Buprenorphine—OPRL1—GPCR downstream signaling—IL2RA—vitiligo	7.05e-05	0.00321	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—MC1R—vitiligo	6.97e-05	0.00317	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—SH2B3—vitiligo	6.83e-05	0.00311	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—GZMB—vitiligo	6.79e-05	0.00309	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—MC1R—vitiligo	6.73e-05	0.00307	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—GSTT1—vitiligo	6.52e-05	0.00297	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—GSTT1—vitiligo	6.46e-05	0.00294	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling by GPCR—IL2RA—vitiligo	6.41e-05	0.00292	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—MC1R—vitiligo	6.11e-05	0.00278	CbGpPWpGaD
Buprenorphine—ABCB1—Allograft Rejection—CD80—vitiligo	6.11e-05	0.00278	CbGpPWpGaD
Buprenorphine—CYP1A2—Phase II conjugation—GSTM1—vitiligo	6.01e-05	0.00274	CbGpPWpGaD
Buprenorphine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—vitiligo	5.93e-05	0.0027	CbGpPWpGaD
Buprenorphine—CYP3A5—Biological oxidations—GSTM1—vitiligo	5.84e-05	0.00266	CbGpPWpGaD
Buprenorphine—CYP3A5—Metapathway biotransformation—GSTM1—vitiligo	5.76e-05	0.00262	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—CCR6—vitiligo	5.73e-05	0.00261	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—MC1R—vitiligo	5.69e-05	0.00259	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—GSTT1—vitiligo	5.52e-05	0.00252	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—CCR6—vitiligo	5.21e-05	0.00237	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—MC1R—vitiligo	5.16e-05	0.00235	CbGpPWpGaD
Buprenorphine—CYP2C8—Biological oxidations—GSTM1—vitiligo	5.06e-05	0.0023	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—CCR6—vitiligo	5.03e-05	0.00229	CbGpPWpGaD
Buprenorphine—CYP2C8—Metapathway biotransformation—GSTM1—vitiligo	4.99e-05	0.00227	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—CCR6—vitiligo	4.56e-05	0.00208	CbGpPWpGaD
Buprenorphine—CYP2C19—Biological oxidations—GSTM1—vitiligo	4.51e-05	0.00206	CbGpPWpGaD
Buprenorphine—CYP2C19—Metapathway biotransformation—GSTM1—vitiligo	4.45e-05	0.00203	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—GSTT1—vitiligo	4.26e-05	0.00194	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—CCR6—vitiligo	4.25e-05	0.00194	CbGpPWpGaD
Buprenorphine—CYP2D6—Biological oxidations—GSTM1—vitiligo	4.15e-05	0.00189	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—MC1R—vitiligo	4.12e-05	0.00188	CbGpPWpGaD
Buprenorphine—CYP2C9—Biological oxidations—GSTM1—vitiligo	4.12e-05	0.00188	CbGpPWpGaD
Buprenorphine—CYP2D6—Metapathway biotransformation—GSTM1—vitiligo	4.09e-05	0.00187	CbGpPWpGaD
Buprenorphine—CYP2C9—Metapathway biotransformation—GSTM1—vitiligo	4.06e-05	0.00185	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—CCR6—vitiligo	3.86e-05	0.00176	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—IL2RA—vitiligo	3.78e-05	0.00172	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—MC1R—vitiligo	3.61e-05	0.00164	CbGpPWpGaD
Buprenorphine—CYP1A2—Biological oxidations—GSTM1—vitiligo	3.52e-05	0.0016	CbGpPWpGaD
Buprenorphine—CYP1A2—Metapathway biotransformation—GSTM1—vitiligo	3.47e-05	0.00158	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GSTT1—vitiligo	3.26e-05	0.00149	CbGpPWpGaD
Buprenorphine—OPRL1—Signaling Pathways—CD80—vitiligo	3.16e-05	0.00144	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CCR6—vitiligo	3.07e-05	0.0014	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—MC1R—vitiligo	3.05e-05	0.00139	CbGpPWpGaD
Buprenorphine—OPRD1—GPCR downstream signaling—IL2RA—vitiligo	3.01e-05	0.00137	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—SH2B3—vitiligo	2.91e-05	0.00133	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—GZMB—vitiligo	2.9e-05	0.00132	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling by GPCR—IL2RA—vitiligo	2.73e-05	0.00125	CbGpPWpGaD
Buprenorphine—CYP3A4—Biological oxidations—GSTM1—vitiligo	2.71e-05	0.00124	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CD44—vitiligo	2.71e-05	0.00124	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CCR6—vitiligo	2.7e-05	0.00123	CbGpPWpGaD
Buprenorphine—CYP3A4—Metapathway biotransformation—GSTM1—vitiligo	2.68e-05	0.00122	CbGpPWpGaD
Buprenorphine—OPRK1—GPCR downstream signaling—IL2RA—vitiligo	2.64e-05	0.0012	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTT1—vitiligo	2.58e-05	0.00117	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—SH2B3—vitiligo	2.56e-05	0.00116	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—GZMB—vitiligo	2.54e-05	0.00116	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling by GPCR—IL2RA—vitiligo	2.4e-05	0.00109	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CCR6—vitiligo	2.28e-05	0.00104	CbGpPWpGaD
Buprenorphine—OPRM1—GPCR downstream signaling—IL2RA—vitiligo	2.23e-05	0.00102	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—CAT—vitiligo	2.2e-05	0.001	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTT1—vitiligo	2.19e-05	0.000997	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTT1—vitiligo	2.17e-05	0.000988	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—SH2B3—vitiligo	2.16e-05	0.000984	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—GZMB—vitiligo	2.15e-05	0.000978	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CD44—vitiligo	2.14e-05	0.000976	CbGpPWpGaD
Buprenorphine—CYP2C18—Metabolism—GSTM1—vitiligo	2.08e-05	0.000947	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling by GPCR—IL2RA—vitiligo	2.03e-05	0.000923	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTT1—vitiligo	1.99e-05	0.000906	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CD44—vitiligo	1.82e-05	0.000828	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CD44—vitiligo	1.8e-05	0.000821	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—CAT—vitiligo	1.74e-05	0.000792	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CD44—vitiligo	1.65e-05	0.000753	CbGpPWpGaD
Buprenorphine—UGT1A9—Metabolism—GSTM1—vitiligo	1.64e-05	0.000748	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—IL2RA—vitiligo	1.62e-05	0.000736	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTT1—vitiligo	1.57e-05	0.000714	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—CAT—vitiligo	1.48e-05	0.000672	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—CAT—vitiligo	1.46e-05	0.000666	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—IL2RA—vitiligo	1.42e-05	0.000645	CbGpPWpGaD
Buprenorphine—ABCG2—Metabolism—GSTM1—vitiligo	1.39e-05	0.000635	CbGpPWpGaD
Buprenorphine—CYP3A7—Metabolism—GSTM1—vitiligo	1.38e-05	0.000629	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTT1—vitiligo	1.36e-05	0.000619	CbGpPWpGaD
Buprenorphine—OPRD1—Signaling Pathways—CD80—vitiligo	1.35e-05	0.000614	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—CAT—vitiligo	1.34e-05	0.000611	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CD44—vitiligo	1.3e-05	0.000594	CbGpPWpGaD
Buprenorphine—CYP2A6—Metabolism—GSTM1—vitiligo	1.27e-05	0.000577	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTT1—vitiligo	1.21e-05	0.000552	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—IL2RA—vitiligo	1.2e-05	0.000545	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTT1—vitiligo	1.18e-05	0.000539	CbGpPWpGaD
Buprenorphine—OPRK1—Signaling Pathways—CD80—vitiligo	1.18e-05	0.000539	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CD44—vitiligo	1.13e-05	0.000514	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTT1—vitiligo	1.11e-05	0.000508	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTT1—vitiligo	1.11e-05	0.000503	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—CAT—vitiligo	1.06e-05	0.000482	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CD44—vitiligo	1.01e-05	0.000459	CbGpPWpGaD
Buprenorphine—OPRM1—Signaling Pathways—CD80—vitiligo	9.99e-06	0.000455	CbGpPWpGaD
Buprenorphine—CYP3A5—Metabolism—GSTM1—vitiligo	9.99e-06	0.000455	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CD44—vitiligo	9.83e-06	0.000448	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTT1—vitiligo	9.44e-06	0.00043	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CD44—vitiligo	9.26e-06	0.000422	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CD44—vitiligo	9.18e-06	0.000418	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—CAT—vitiligo	9.16e-06	0.000417	CbGpPWpGaD
Buprenorphine—CYP2C8—Metabolism—GSTM1—vitiligo	8.65e-06	0.000394	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—CAT—vitiligo	8.17e-06	0.000372	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—CAT—vitiligo	7.98e-06	0.000363	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CD44—vitiligo	7.85e-06	0.000358	CbGpPWpGaD
Buprenorphine—CYP2C19—Metabolism—GSTM1—vitiligo	7.72e-06	0.000352	CbGpPWpGaD
Buprenorphine—ABCB1—Metabolism—GSTM1—vitiligo	7.53e-06	0.000343	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—CAT—vitiligo	7.52e-06	0.000343	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—CAT—vitiligo	7.45e-06	0.00034	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTT1—vitiligo	7.29e-06	0.000332	CbGpPWpGaD
Buprenorphine—CYP2D6—Metabolism—GSTM1—vitiligo	7.1e-06	0.000323	CbGpPWpGaD
Buprenorphine—CYP2C9—Metabolism—GSTM1—vitiligo	7.04e-06	0.000321	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—CAT—vitiligo	6.37e-06	0.00029	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CD44—vitiligo	6.06e-06	0.000276	CbGpPWpGaD
Buprenorphine—CYP1A2—Metabolism—GSTM1—vitiligo	6.01e-06	0.000274	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—CAT—vitiligo	4.92e-06	0.000224	CbGpPWpGaD
Buprenorphine—CYP3A4—Metabolism—GSTM1—vitiligo	4.64e-06	0.000211	CbGpPWpGaD
